Sawada T, Sugimoto T, Kawakatsu H, Matsumura T, Matsuda Y
Department of Pediatrics, Kyoto Prefectural University of Medicine, Japan.
Pediatr Hematol Oncol. 1991 Apr-Jun;8(2):93-109. doi: 10.3109/08880019109033437.
The present status of the neuroblastoma mass screening program in Japan, the first national trial in the world, is evaluated. This program, now in its fifth year, was conducted in cooperation with the infants' mothers, local health centers, screening centers, and selected hospitals. From the onset of the program in Kyoto in 1973 to the end of 1989, 337 cases were detected and analyzed. Most cases were detected at early stages and 97% are expected to be cured. Several social, technical, and clinical problems remain unresolved.
对日本神经母细胞瘤群体筛查项目的现状进行了评估，该项目是世界上首个全国性试验。这个项目目前处于第五年，是与婴儿母亲、当地卫生中心、筛查中心及选定医院合作开展的。从1973年该项目在京都启动到1989年底，共检测并分析了337例病例。大多数病例在早期被检测出，预计97%的病例可治愈。一些社会、技术和临床问题仍未得到解决。
